Drug Discovery News: Breaking Drug Discovery News, Comments and Articles. - Page: 4

16:57 EDT 29th August 2015 | BioPortfolio

Drug Discovery News - Page: 4Twitter RSS

Read the latest Drug Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Drug Discovery.

Search or Follow Our Drug Discovery - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Drug Discovery - Page: 4 News.
You can also follow our Drug Discovery - Page: 4 news stories on Twitter: @DiscoveryDrug

Showing "drug drug discovery discovery" News Articles 76 to 100 of 24,000+

Friday 28th August 2015

FDA takes action against three tobacco manufacturers for making 'additive-free' and/or 'natural' claims on cigarette labelling

The US Food and Drug Administration has issued warning letters to three tobacco manufacturers — ITG Brands LLC, Santa Fe Natural Tobacco Company Inc., and Sherman’s 1400 Broadway N.Y.C. Ltd. — who describe their cigarettes on product labelling ...

Why Switzerland Approval Of Exelixis And Roche Drug Combination For Melanoma Is A Big Deal

FDA approves Amgen’s cholesterol lowering drug

The FDA has endorsed Amgen’s cholesterol-lowering medication, Repatha, for the use in patients with high cholesterol. It follows Amgen’s successful EU approval of Repatha (evolocumab) earlier in the summer. The injectable drug is a human monoclonal antibody, which works by making the liver more efficient at getting rid of low-density lipoprotein cholesterol (LDL-C), or ‘bad’ cholesterol, f...

Gero: Physics Meets Biology to Help Defeat Aging

HONG KONG, August 28, 2015 /PRNewswire/ -- The scientific team of a new biotech company Gero in collaboration with one of the leading academics in the field of aging Prof. Robert J. Shmookler Reis (current world record holder in life extension for model animals - 10 fold for nematodes) has recently brought new insights into biology of aging and age-related diseases, primarily, around the stabilit...

Passport Health To Participate In Typhoid Vaccine Study

SCOTTSDALE, Ariz., Aug. 28, 2015 /PRNewswire-USNewswire/ -- Passport Health, in partnership with vaccine manufacturer PaxVax, Inc. is participating in a clinical study to test the effects of the oral typhoid vaccination, Vivotif® (Typhoid Vaccine Live Oral Ty21a). The study will look at the side effects that could occur when taking Vivotif across the range of approved potencies. The stud...

World’s biggest cardiology congress comes to London

The world's biggest cardiology congress kicks off in London on Saturday, with academics, heart specialists and pharma companies unveiling the latest insights into one of the world's biggest killers.The European Society of Cardiology (ESC) congress is...

NHS looks to ESC for next-gen heart drug data

New data is expected to be presented at the European Cardiology Society congress in London, on the high cholesterol drugs that are set to battle for market access in the UK. Amgen’s Repatha (evolocumab) was the first in this new class of drugs - called PCSK9 inhibitors - to be approved, when it was signed off by the European Commission in July and has been approved by the FDA today. Image...

Cholesterol drug from Amgen gets FDA OK

Amgen's Repatha, or evolocumab, has obtained approval from the FDA as a treatment for familial hypercholesterolemia, as well  -More- 

Boehringer, Eli Lilly receive FDA approval for diabetes combination drug

The FDA granted approval to Boehringer Ingelheim's and Eli Lilly & Co.'s Synjardy, a fixed-dose combination of empagliflozin  -More- 

FDA approves Aurobindo hepatitis B treatment

Aurobindo Pharma's abbreviated new drug application to market entecavir tablets, a generic version of Bristol-Myers Squibb's  -More- 

@USANAInc Makes Fast 50 List Once Again

SALT LAKE CITY, Aug. 28, 2015 /PRNewswire/ -- Announced yesterday afternoon, USANA Health Sciences (NYSE: USNA) was named to the Utah Business Fast 50 List for 2015. This is the eighth time the Salt Lake-based nutritional company has made the list of the fastest growing companies in the state of Utah. USANA was recognized at the Utah Business award ceremony based on its most recent five years o...

Buy Eli Lilly, or Will Drug-Pricing Debate Dent the Stock?

Click to view a price quote on LLY. Click to research the Drugs industry.

Time to Buy Amgen After Newly Approved Drug?

Click to view a price quote on AMGN. Click to research the Drugs industry.

Brain scans predict response to antipsychotic medications

Investigators have discovered that brain scans can be used to predict patients' response to antipsychotic drug treatment.

Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound

Riordan-McKenna Institute founders, stem cell expert Neil Riordan, PhD and orthopedic surgeon, Wade McKenna, DO, announced today that the use of sterile, dehydrated amniotic tissue AlphaPATCH™ developed by Amniotic Therapies in Dallas, Texas, resulted in complete healing of an otherwise non-healing surgical knee wound. Dallas, Texas (PRWEB) August 28, 2015 Riordan-McKenna Institute founders, st...

National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update

Attorneys representing persons involved in testosterone lawsuits alleging heart attack and stroke for the Onder Law Firm provide an update on recent court developments. While AbbVie attorneys press for a cap on custodians, plaintiffs' counsel demands more time for research. St. Louis, MO (PRWEB) August 28, 2015 The Plaintiffs Steering Committee (PSC) and the defendants in testosterone lawsuit...

Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery

Rochester, NY (PRWEB) August 28, 2015 The Quatela Center for Plastic Surgery is excited to bring patients the ground breaking injectable, Kybella™. It is the first and only non...

Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat

Mendon, IL (PRWEB) August 28, 2015 Mendon, IL, home of the Adams County Fairgrounds, was treated once again to a fun-filled evening of good music and good people, all for a good caus...

$1Billion Negative Pressure Wound Therapy Market (by 2021) Analysis and Forecasts Report

PUNE, India, August 28, 2015 /PRNewswire/ -- The MediPoint: Negative Pressure Wound Therapy - Global Analysis and Market Forecasts research report forecasts a 6.2% CAGR for NPWT market that is projected to value $1.07 Billion by 2021 from an estimated $700 million by 2014. Complete report on negative pressure wound therapy market spread across 248 pages, mentioning 17 companies and supported wit...

Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan

SEOUL, South Korea, Aug. 28, 2015 /PRNewswire/ -- Joint research by Prof. Kim from Chungbuk National University and Dr. Ra from Biostar Published in 'Stem Cells Translational Medicine' (IF 5.7) Confirmed 30% increase of lifespan through multiple IV administration of Adipose-derived MSC Increase in cognitive function, physical vitality, and life expectancy found Commercialization within ...

DPP-4 Inhibitors for Type 2 Diabetes: Drug Safety Communication - May Cause Severe Joint Pain

Audience: Patient, Endocrinology, Family Practice, Internal Medicine ISSUE: The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines sitagliptin, saxagliptin, linagliptin, and alogliptin may cause joint pain that can....

FDA Approves Lilly/BI Diabetes Drug Synjardy

Synjardy is a combination of empagliflozin and metformin.

US approves injectable anti-cholesterol drug Repatha

US regulators on Thursday approved Repatha, the second injectable drug of its kind designed for certain patients with stubbornly high cholesterol which puts them at risk of heart disease. Repatha, also known as evolocumab, is made by Amgen and is par...

Oscotec Plans US Trial For SYK Inhibitor Amid Failures By Others

South Korean drug developer Oscotec is planning to conduct early stage clinical trials in the US for its spleen tyrosine kinase inhibitor to treat rheumatoid arthritis. The company is betting that it will be able to license out the drug candidate, wh...

FDA Approves Amgen’s PCSK9 Inhibitor Repatha

The drug was the first PCSK9 inhibitor approved in Europe and the second approved in the US. Date:  Fri, 2015-08-28 (All day) Article sort author:  ...


News Quicklinks